Coronary artery calcium score: Current status of clinical application and how to handle the results

Author(s):  
Yasuyuki Suzuki ◽  
Naoya Matsumoto ◽  
Shunichi Yoda ◽  
Yasuo Amano ◽  
Yasuo Okumura
2017 ◽  
Vol 50 (3) ◽  
pp. 182-189 ◽  
Author(s):  
Priscilla Ornellas Neves ◽  
Joalbo Andrade ◽  
Henry Monção

Abstract The coronary artery calcium score plays an Important role In cardiovascular risk stratification, showing a significant association with the medium- or long-term occurrence of major cardiovascular events. Here, we discuss the following: protocols for the acquisition and quantification of the coronary artery calcium score by multidetector computed tomography; the role of the coronary artery calcium score in coronary risk stratification and its comparison with other clinical scores; its indications, interpretation, and prognosis in asymptomatic patients; and its use in patients who are symptomatic or have diabetes.


2021 ◽  
Vol 77 (18) ◽  
pp. 1351
Author(s):  
Alexei Savtchenko ◽  
Cvetan Trpkov ◽  
Jane Liang ◽  
Danielle Southern ◽  
Stephen Wilton ◽  
...  

2021 ◽  
Vol 35 ◽  
pp. 100827
Author(s):  
Cvetan Trpkov ◽  
Alexei Savtchenko ◽  
Zhiying Liang ◽  
Patrick Feng ◽  
Danielle A. Southern ◽  
...  

2021 ◽  
Vol 10 (6) ◽  
pp. 1220
Author(s):  
Thomas Senoner ◽  
Fabian Plank ◽  
Christoph Beyer ◽  
Christian Langer ◽  
Katharina Birkl ◽  
...  

Background: The coronary artery calcium score (CACS) is a powerful tool for cardiovascular risk stratification. Coronary computed tomography angiography (CTA) allows for a more distinct analysis of atherosclerosis. The aim of the study was to assess gender differences in the atherosclerosis profile of CTA in patients with a CACS of zero. Methods: A total of 1451 low- to intermediate-risk patients (53 ± 11 years; 51% females) with CACS <1.0 Agatston units (AU) who underwent CTA and CACS were included. Males and females were 1:1 propensity score-matched. CTA was evaluated for stenosis severity (Coronary Artery Disease – Reporting and Data System (CAD-RADS) 0–5: minimal <25%, mild 25–49%, moderate 50–69%, severe ≥70%), mixed-plaque burden (G-score), and high-risk plaque (HRP) criteria (low-attenuation plaque, spotty calcification, napkin-ring sign, and positive remodeling). All-cause mortality, cardiovascular mortality, and major cardiovascular events (MACEs) were collected. Results: Among the patients, 88.8% had a CACS of 0 and 11.2% had an ultralow CACS of 0.1–0.9 AU. More males than females (32.1% vs. 20.3%; p < 0.001) with a CACS of 0 had atherosclerosis, while, among those with an ultralow CACS, there was no difference (88% vs. 87.1%). Nonobstructive CAD (25.9% vs. 16.2%; p < 0.001), total plaque burden (2.2 vs. 1.4; p < 0.001), and HRP were found more often in males (p < 0.001). After a follow-up of mean 6.6 ± 4.2 years, all-cause mortality was higher in females (3.5% vs. 1.8%, p = 0.023). Cardiovascular mortality and MACEs were low (0.2% vs. 0%; p = 0.947 and 0.3% vs. 0.6%; p = 0.790) for males vs. females, respectively. Females were more often symptomatic for chest pain (70% vs. 61.6%; p = 0.004). (4) Conclusions: In patients with a CACS of 0, males had a higher prevalence of atherosclerosis, a higher noncalcified plaque burden, and more HRP criteria. Nonetheless, females had a worse long–term outcome and were more frequently symptomatic.


Sign in / Sign up

Export Citation Format

Share Document